These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 1602823

  • 1. Generation of nucleoside-resistant variants of HIV-1 by in vitro selection in the presence of AZT or DDI but no by combinations.
    Gao Q, Parniak MA, Gu Z, Wainberg MA.
    Leukemia; 1992; 6 Suppl 3():192S-195S. PubMed ID: 1602823
    [Abstract] [Full Text] [Related]

  • 2. Generation of multiple drug resistance by sequential in vitro passage of the human immunodeficiency virus type 1.
    Gao Q, Gu Z, Salomon H, Nagai K, Parniak MA, Wainberg MA.
    Arch Virol; 1994; 136(1-2):111-22. PubMed ID: 8002779
    [Abstract] [Full Text] [Related]

  • 3. Two-drug combinations of zidovudine, didanosine, and recombinant interferon-alpha A inhibit replication of zidovudine-resistant human immunodeficiency virus type 1 synergistically in vitro.
    Johnson VA, Merrill DP, Videler JA, Chou TC, Byington RE, Eron JJ, D'Aquila RT, Hirsch MS.
    J Infect Dis; 1991 Oct; 164(4):646-55. PubMed ID: 1716649
    [Abstract] [Full Text] [Related]

  • 4. In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine.
    Gao Q, Gu ZX, Parniak MA, Li XG, Wainberg MA.
    J Virol; 1992 Jan; 66(1):12-9. PubMed ID: 1727474
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine.
    Gu Z, Gao Q, Li X, Parniak MA, Wainberg MA.
    J Virol; 1992 Dec; 66(12):7128-35. PubMed ID: 1279198
    [Abstract] [Full Text] [Related]

  • 9. [In vitro selection and phenotyping of HIV-1 mutants resistant to azidothymidine and didanosine].
    Kiseleva IaIu, Pliasunova OA, Pokrovskaia NV, Pokrovskiĭ AG.
    Antibiot Khimioter; 2005 Dec; 50(5-6):11-6. PubMed ID: 16526603
    [Abstract] [Full Text] [Related]

  • 10. Loss of synergistic response to combinations containing AZT in AZT-resistant HIV-1.
    Cox SW, Albert J, Wahlberg J, Uhlén M, Wahren B.
    AIDS Res Hum Retroviruses; 1992 Jul; 8(7):1229-34. PubMed ID: 1520536
    [Abstract] [Full Text] [Related]

  • 11. Changes in drug sensitivity of human immunodeficiency virus type 1 during therapy with azidothymidine, dideoxycytidine, and dideoxyinosine: an in vitro comparative study.
    Shirasaka T, Yarchoan R, O'Brien MC, Husson RN, Anderson BD, Kojima E, Shimada T, Broder S, Mitsuya H.
    Proc Natl Acad Sci U S A; 1993 Jan 15; 90(2):562-6. PubMed ID: 8380641
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations.
    Shafer RW, Kozal MJ, Winters MA, Iversen AK, Katzenstein DA, Ragni MV, Meyer WA, Gupta P, Rasheed S, Coombs R.
    J Infect Dis; 1994 Apr 15; 169(4):722-9. PubMed ID: 8133086
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Natural resistance of human immunodeficiency virus type 2 to zidovudine.
    Reid P, MacInnes H, Cong ME, Heneine W, García-Lerma JG.
    Virology; 2005 Jun 05; 336(2):251-64. PubMed ID: 15892966
    [Abstract] [Full Text] [Related]

  • 16. Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine.
    García-Lerma JG, MacInnes H, Bennett D, Weinstock H, Heneine W.
    J Virol; 2004 Jul 05; 78(14):7545-52. PubMed ID: 15220429
    [Abstract] [Full Text] [Related]

  • 17. Ganciclovir antagonizes the anti-human immunodeficiency virus type 1 activity of zidovudine and didanosine in vitro.
    Medina DJ, Hsiung GD, Mellors JW.
    Antimicrob Agents Chemother; 1992 May 05; 36(5):1127-30. PubMed ID: 1510405
    [Abstract] [Full Text] [Related]

  • 18. Didanosine and zidovudine resistance patterns in clinical isolates of human immunodeficiency virus type 1 as determined by a replication endpoint concentration assay.
    McLeod GX, McGrath JM, Ladd EA, Hammer SM.
    Antimicrob Agents Chemother; 1992 May 05; 36(5):920-5. PubMed ID: 1510414
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and in vitro activity of long-chain 5'-O-[(alkoxycarbonyl)phosphinyl]-3'-azido-3'-deoxythymidines against wild-type and AZT- and foscarnet-resistant strains of HIV-1.
    Rosowsky A, Fu H, Pai N, Mellors J, Richman DD, Hostetler KY.
    J Med Chem; 1997 Aug 01; 40(16):2482-90. PubMed ID: 9258355
    [Abstract] [Full Text] [Related]

  • 20. Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision.
    Boyer PL, Imamichi T, Sarafianos SG, Arnold E, Hughes SH.
    J Virol; 2004 Sep 01; 78(18):9987-97. PubMed ID: 15331732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.